TRIPELENNAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Tripelennamine Hydrochloride patents expire, and when can generic versions of Tripelennamine Hydrochloride launch?
Tripelennamine Hydrochloride is a drug marketed by Anabolic, Barr, Heather, Impax Labs, Lannett, Nylos, Parke Davis, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in TRIPELENNAMINE HYDROCHLORIDE is tripelennamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tripelennamine hydrochloride profile page.
Summary for TRIPELENNAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 715 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRIPELENNAMINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRIPELENNAMINE HYDROCHLORIDE
US Patents and Regulatory Information for TRIPELENNAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anabolic | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083037-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Parke Davis | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083625-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Impax Labs | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 080785-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Parke Davis | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083626-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
